Octagam (Human Normal Immunoglobulin)

Octagam is an immunoglobulin used to replace deficient antibodies and modify immune responses in several clinical settings.

• Primary immunodeficiency diseases: restores normal immunoglobulin levels and reduces infection frequency.
• Secondary immunodeficiency (e.g., chronic lymphocytic leukemia, HIV infection): provides passive immunity to lower infection risk.
• Hematopoietic stem cell transplantation (HSCT) conditioning: helps prevent graft‑versus‑host disease and infection complications.
• Immune thrombocytopenic purpura (ITP) refractory to steroids: raises platelet counts by modulating auto‑antibody activity.
• Kawasaki disease with coronary artery involvement: reduces inflammation and aneurysm formation.

• Octagam supplies pooled human IgG antibodies that bind to a broad spectrum of pathogens and toxins, facilitating opsonization and complement activation. The infused immunoglobulin also modulates Fc‑receptor signaling and cytokine production, leading to down‑regulation of auto‑reactive immune cells and restoration of immune homeostasis.

Adverse reactions to Octagam are generally related to infusion and immune modulation.

Common Side Effects

• Headache
• Mild fever
• Chills or rigors
• Nausea
• Fatigue
• Injection site erythema

Serious or Rare Side Effects

• Anaphylaxis or severe hypersensitivity
• Acute hemolytic anemia
• Renal impairment or acute kidney injury
• Thromboembolic events
• Aseptic meningitis
• Severe thrombocytopenia

Octagam should be administered under medical supervision with attention to patient‑specific risk factors.

• Assess renal function: adjust infusion rate in patients with renal impairment.
• Screen for IgA deficiency: patients with anti‑IgA antibodies may develop severe reactions.
• Monitor for thrombotic risk: consider prophylaxis in patients with known hypercoagulability.
• Evaluate cardiac status: rapid infusions can cause fluid overload in heart‑failure patients.
• Observe for signs of infection: immunoglobulin does not treat active infections.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Octagam may interact with other agents that affect immune function or renal clearance.

Major Interactions (Avoid)

• Live vaccines: concurrent use can diminish vaccine efficacy and increase adverse events.
• High‑dose aspirin or other NSAIDs: may increase risk of renal dysfunction when combined with immunoglobulin.

Moderate Interactions (Monitor Closely)

• Diuretics: may potentiate fluid shifts during infusion.
• Anticoagulants (e.g., warfarin): monitor coagulation parameters as immunoglobulin can affect clotting factors.
• ACE inhibitors: watch for additive renal effects.
• Rituximab or other B‑cell depleting agents: may alter therapeutic response.
• Corticines (corticost ).